C3 and cancer: Recent study showed that C3 was upregulated in leptomeningeal metastatic models and necessary for cancer growth, as it could activate the C3a receptor in the choroid plexus epithelium to disrupt the blood-CSF barrier that allowed cancer cell growth (22), suggesting C3 is a predictive indicator for cancer with a strong clinical value.